MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202618083447 A) filed by Daiichi Sankyo Co. , Ltd. on July 07, 2026, for Anti-Muc1 Antibody-Drug Conjugate.
Inventors include Gellert, Johanna; Flechner, Anke; Weigelt, Doreen; Danielczyk, Antje; and Nagase, Akiko.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present disclosure relates to antibody drug conjugates directed against the cancer antigen MUC1. In particular, an antibody with improved antigen binding was obtained by deleting a glycosylation site in the CDR-H2 of a known anti-MUC1 antibody. The conjugates consist of exatecan derivatives coupled to the anti MUC1 antibodies.
Disclaimer: Curated by HT Syndication.
